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Intraviral protein-protein interactions are critical for virus survival in the host. Discovery of such
interactions is important to understand molecular mechanisms of viral replication and
pathogenesis. The development of a cell-based assay that can be employed to examine
systematically viral protein interactions is described. The method, known as the Split Luciferase
Complementation Assay (SLCA), is based on the principle that N- and C-terminal domains of
luciferase alone do not emit luminescence; however, if fused to interacting proteins the two nonfunctional halves can be brought into close enough proximity through a specific protein-protein
interaction to restore the functions of the enzyme and emit detectable light. The well-studied
influenza B polymerase acidic protein (PA) and basic protein 1 (PB1) interaction was used as a
model system to develop the assay. Consistent with previous studies, a strong PA-PB1 interaction
was demonstrated in the assay. The PA-PB1 interaction was also disrupted by single amino acid
mutations in the N-terminal domain of PB1 that is responsible for binding PA. The described
SLCA is highly specific and easy to perform, and thus may be useful for studying protein-protein
interactions in viral diseases.

Keywords
viral disease; protein-protein interaction; Split Luciferase Complementation Assay
Virus infection is an intracellular event that depends on a highly connected, dynamic, and
regulated network of protein-protein interactions (PPIs). It is generally believed that proteinprotein interactions can be divided into two major categories in the context of virus
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infection: intraviral (i.e., virus-virus) and virus-host interactions. Intraviral protein-protein
interactions are essential to virus replication and occur normally among viral structural
proteins, which play an important role in different stages of virus life cycle such as assembly
and release. Virus-host interactions involving both structural and non-structural viral
proteins are believed to serve more complex roles in virus replication and pathogenesis. By
hijacking cellular machineries through protein interactions, viruses can evade host immunity
and replicate in the hosts, causing diseases. Virus-host interactions are also commandeered
to support viral replication and transmission processes such as virus entry, virus genome
transcription, and virus release. Protein interactions are at the heart of virus infections and
the associated diseases. Thus, a study of protein interactions and the molecular principles
that underlie them is critical towards the understanding of virus replication and
pathogenesis. Viral protein-protein interactions can be also targeted for the development of
antiviral therapies in the future.
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Several approaches with high-throughput potential have been developed to study proteinprotein interactions. Of these, the yeast-two-hybrid (Y2H) system is viewed as the standard
assay for the study of protein-protein interactions (Bailer Haas, 2009). This system has been
used previously to study viral protein-protein interactions in cells (Calderwood et al., 2007;
de Chassey et al., 2008; Fossum et al., 2009; Rozen et al., 2008; Uetz et al., 2006). The Y2H
system utilizes a reporter gene which expresses only two fusion proteins that interact
appears to require the fusion proteins to be imported to the nucleus, which may limit the
sensitivity for probing interactions which occur in the cytoplasm. Additional concern is that
the discrepancy has been demonstrated for identified interactions in comparative studies
using Y2H systems (Bailer Haas, 2009). Limitations of Y2H highlight a need for
development of other protein-protein interaction assays that can be used independently to
study protein interactions or as an alternative approach to validate the biological significance
of an interaction identified by Y2H.
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One such approach is the Split Luciferase Complementation Assay (SLCA), where a
luciferase protein is reconstituted when two fusion proteins interact (Cissell et al., 2009;
Fujikawa Kato, 2007; Kaihara et al., 2003; Luker Piwnica-Worms, 2004; Luker et al., 2004;
Paulmurugan Gambhir, 2003; Paulmurugan, Umezawa, Gambhir, 2002). The assay is based
on the principle that N- and C-terminal domains of luciferase alone do not emit
luminescence; however, if fused to interacting proteins the two non-functional halves can be
brought into close enough proximity to form a functional enzyme as a result of appropriate
specific protein interactions (Fig. 1A). Thus, through SLCA, the specific protein-protein
interactions can be detected quantitatively by measuring reassembled luciferase activity in a
microplate luminometer. Due to its sensitive and highly dynamic nature for detecting
protein-protein interactions, this assay is becoming an increasingly popular tool used to
study protein-protein interactions in cell biology and plant science (Cissell et al., 2009;
Fujikawa Kato, 2007; Kaihara et al., 2003; Luker Piwnica-Worms, 2004; Luker et al., 2004;
Paulmurugan Gambhir, 2003; Paulmurugan et al., 2002). An additional advantage is that
unlike split-GFP assay (also known as bimolecular fluorescent complementation assay,
BiFC), the protein complexes formed through SLCA are largely reversible so the
interactions detected are dynamic in nature (Paulmurugan et al., 2004). This assay has been
used previously to study the homodimerization of herpes simplex virus 1 thymidine kinase
(Massoud, Paulmurugan, Gambhir, 2004). In the current work, we sought to apply the Split
Luciferase Complementation Assay to the detection of intraviral protein-protein interactions
using a well-studied influenza B PA-PB1 interaction as a model system. Previous studies
have shown that the N-terminal 25 amino acid residues of influenza B PB1 (PB11–25B) are
sufficient for binding of influenza B PA protein (Deng et al., 2011; Wunderlich et al., 2010;
Wunderlich et al., 2009).
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Renilla luciferase (RL) was selected as an enzyme for the assay and a split approach of
Renilla luciferase was employed involving an N-terminal fragment consisting of amino
acids 1-229 (termed LN) and a C-terminal fragment consisting of amino acids 230-311
(termed LC) (Fig. 1A). This design has been validated previously in an SLCA for the
detection of protein-protein interactions (Fujikawa Kato, 2007). Considering that the
orientation of fusion proteins may sterically affect the association of the RL fragments
subsequently inhibiting enzymatic activity, fusion constructs representing the influenza B
PA and PB1 proteins were generated in multiple configurations (Fig. 1B). To express
influenza B viral polymerase proteins, the eukaryotic expression vector pPRE was used
under the control of both the cytomegalovirus (CMV) immediate-early promoter and the
bovine growth hormone polyadenylation signal as described previously (Patnaik et al., 2002;
Wang et al., 2010). Three steps were required to generate various expression vectors used in
the SLCA study. First, N-terminal fragment (residues 1-229 of Renilla luciferase) were
amplified from the Renilla luciferase expression vector pGL4.76 (Promega) and inserted
into the pPRE vector by digestion with EcoRI/NotI and then re-ligated. The resultant vector
was designated pLN. Second, the same method was used to generate the vector pLC for
expression of the C-terminal fragment (residues 230-311 of Renilla luciferase). Third,
complete open-reading frames encoding PA and PB1 were amplified from an influenza B/
Lee/40 reverse genetic system (Deng et al., 2011) and fused via a protein linker (GGGS x 2)
to the N-terminus or C-terminus of the LN or LC fragments, respectively, which resulted in
two groups of fusion plasmids: the PA group (PA-LN, PA-PC, LN-PA, and LC-PA) and the
PB1 group (PB1-LC, LN-PB1, and LC-PB1). Primers and sequence information for each
construct is available upon request. Initial screening of all possible combinations of SLCA
PA/PB1 pairs for reconstituted RL enzymatic activity resulted in the identification of an
interacting PA/PB1 pair (PA-LC and LN-PB1), which exhibited the highest activity
(~15000RLU) (Fig. 1C). Thus, the PA-LC and LN-PB1 pair became the focus of our study.
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COS-1 cells were cultured in Dulbecco’s minimal essential medium (DMEM) supplemented
with 10% fetal bovine serum and grown on 12-well plates. Cells were then transfected using
TransIT-LT1 (Mirus) following the procedures outlined by the manufacturer with PA-LC
and LN-PB1 or LN empty vector (0.5 μg each plasmid). At 48 h post-transfection, cell
lysates were collected to measure luciferase activity as a function of protein-protein
interactions using a luciferase assay system (Promega) following the manufacturer’s
recommendations. Transfection with both PA-LC and empty LN vectors served as a
specificity control. As demonstrated in Fig. 1D, transfections involving PA-LC/LN
constructs resulted in very low background signals (~120RLU), while transfections with a
PA/PB1 pair (PA-LC/LN-PB1) produced ~4800RLU. ~40-fold increase of luciferase
activity against the background observed in the PA-LC/LN-PB1 pair indicated that SLCA is
robust and specific in detecting PA-PB1 interaction.
This approach was then validated by targeting the PA-PB1 interaction interface. To designa
rational mutation that disrupts the PA-PB1 interface, we took advantage of a recently solved
high-resolution structure of the influenza A RNA polymerase (PA-PB1) complex, and used
it as a template to model the influenza B PA-PB1 interface (He et al., 2008; Obayashi et al.,
2008). Due to the lack of any deletions or insertions and high sequence identity (~33 and
~60% for PA and PB1, respectively) between influenza A and B virus polymerase proteins
(data not shown), the influenza B PA-PB1 interaction interface can be readily modeled on
the influenza A virus template (Fig. 2A). Examining the modeled PA-PB1 interface revealed
that some of the key residues within the N-terminal domain of PB1 (i.e., PA-binding
domain) that contribute to the PA-PB1 interface are identical between the two viruses (Fig.
2A). For example, three nonpolar helical residues (P5, L8, and F9) in the influenza A PB1
N-terminal domain that have been shown to be critical in the helical stability and provide
apolar contacts with PA are present at the same positions in the influenza B PB1 protein (He
J Virol Methods. Author manuscript; available in PMC 2012 October 23.
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et al., 2008; Obayashi et al., 2008). P5 and Y6 were chosen as targeted residues for sitespecific mutagenesis because the structural and biological importance of these two residues
in the influenza A PA-PB1 interaction has been well-elucidated (He et al., 2008; Obayashi et
al., 2008). As demonstrated in Fig. 2B, mutation of the P5 or Y6 residue to an alanine
residue had no obvious effect on fusion protein expression but inhibited PB1 binding to PA
by approximately 65% (Y6A) and 73% (P5A), respectively, further indicating the assays’
specificity in detecting PA-PB1 interaction of influenza B virus.
In summary, a simple and specific split luciferase complementation assay was developed
which can be used for detecting viral protein-protein interactions. SLCA is straightforward
and can be performed easily using a luminometer and standard molecular biology and cell
culture reagents. With the potential automation in a high-throughput screening format, this
assay can be used alone or in conjunction with Y2H or other assays to study viral proteinprotein interactions and to reveal the intricate networks that viruses employ to benefit their
replication in the host. This information is useful for the design novel antiviral agents to
treat viral diseases and overcome drug resistance associated with current antiviral drugs.
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Figure 1. Split luciferase complementation-based strategy for detection of protein-protein
interaction
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(A) Schematic representation of the assay principal for the detection of protein-protein
interactions. Proteins A and B are fused to N- and C-terminal fragments of luciferase,
respectively. In the absence of an interaction between A and B, the luciferase halves remain
non-functional. Following interaction between A and B, a functional luciferase is
reconstituted which exhibits emission of light upon the addition of appropriate substrate.
LN, N-terminal 229 residues of Renila luciferase; LC, C-terminal 82 residues of Renila
luciferase. (B) Schematic representation of constructs used in the split luciferase
complementation assay (SLCA). All constructs were verified by sequencing in both
directions. (C) SLCA detects protein-protein interaction. COS-1 cells in a 12-well cell
culture plate were transfected with indicated pairs of fusion constructs (0.5μg each plasmid).
At 48 h post transfection, cells were lysed to determine reconstituted Renilla luciferase
reporter activity in a luciferase assay system (Promega) coupled with a BioTek Synergy 2
Multi-detection Microplate Reader (BioTekInstruments) according to the manufacturer’s
recommendations. All experiments were measured in duplicate and repeated in triplicate.
(D) SLCA specificity. COS-1 cells in a 12-well plate were transfected with PA-LC with
empty LN vector or LN-PB1. At 48 h post transfection, the luciferase activities as a result of
the association of LN and LC fragments through protein-protein interactions were measured
as described above. Results represent the mean of three independent experiments plus
standard deviation.
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Figure 2. Modeled interface of influenza B PA-PB1 complex and validation of SLCA approach in
detecting PA-PB1 interaction

(A) Influenza B PA-PB1 complex (top panel) with PA (green) and PB1 (red) highlighting
the interface (top panel) with the interacting residues (PB1, red and PA, green) detailed in
the bottom panel. (B) Validation of SLCA approach. COS-1 cells were transfected with
either a WT PA/PB1 construct (PA-LC/LN-PB1) or mutant construct pairs (PA-LC/LNPB1P5A and PA-LC/LN-PB1Y6A) which contained a substitution of an alanine for proline at
position 5 or for tyrosine at position 6 in PB1 N-terminal domain responsible for binding
PA. At 48 h posttransfection, cells were harvested and then lysed for characterization of
protein expression by a western-blot assay using an anti-Renila Luciferase antibody as well
as by measurement of RL activity. The RLUs of transfected cells by WT PA/PB1 pair was
arbitrarily set at 100%. The RLUs of mutant PA/PB1 pairs were normalized by comparison
with WT pair. Numbers on the left indicate the migration positions of molecular mass
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markers (in kilodaltons). Results represent the mean of three independent experiments plus
standard deviation.

NIH-PA Author Manuscript
NIH-PA Author Manuscript
NIH-PA Author Manuscript
J Virol Methods. Author manuscript; available in PMC 2012 October 23.

View publication stats

